Medicare Enrolled
Dr. Ranjan Sapra, M.D.
Medical Oncology · Fountain Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sapra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sapra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sapra
Dr. Ranjan Sapra is a medical oncology specialist in Fountain Valley, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sapra performed 960 Medicare services across 257 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sapra received a total of $22,318 from 88 pharmaceutical and/or device companies across 942 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sapra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 40% volume in CA
$22,318 industry payments
Medicare Practice Summary
Medicare Utilization ↗960
Medicare services
Top 40% in CA for medical oncology
257
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~53 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $97 | $271 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
338 | $4 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $69 | $191 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
58 | $97 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
49 | $8 | $15 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
32 | $25 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,318
Total received (2018-2024)
Avg $3,188/year across 7 years
Top 30% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
942
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,346 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$972 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,202
2023
$3,121
2022
$3,009
2021
$3,762
2020
$2,940
2019
$3,134
2018
$3,149
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$512
Incyte Corporation
$504
Astellas Pharma US Inc
$278
AstraZeneca Pharmaceuticals LP
$227
Merck Sharp & Dohme LLC
$181
E.R. Squibb & Sons, L.L.C.
$175
Takeda Pharmaceuticals U.S.A., Inc.
$155
GlaxoSmithKline, LLC.
$153
Amgen Inc.
$120
SOBI, INC
$115
Exelixis Inc.
$105
Daiichi Sankyo Inc.
$78
Regeneron Healthcare Solutions, Inc.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Novartis Pharmaceuticals Corporation
$44
Coherus Biosciences Inc.
$42
PharmaEssentia USA Corporation
$42
Gilead Sciences, Inc.
$33
BeiGene USA, Inc.
$32
ABBVIE INC.
$28
Deciphera Pharmaceuticals Inc.
$26
Genentech USA, Inc.
$26
PFIZER INC.
$25
Stemline Therapeutics Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Fennec Pharmaceuticals, Inc.
$23
ARRAY BIOPHARMA INC
$22
TAIHO ONCOLOGY, INC.
$21
Celgene Corporation
$21
Mirati Therapeutics, Inc.
$19
Chiesi USA, Inc.
$18
Acrotech Biopharma Inc.
$14
Top 3 companies account for 40.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,225
Incyte Corporation
$1,599
Janssen Biotech, Inc.
$1,490
E.R. Squibb & Sons, L.L.C.
$1,133
Amgen Inc.
$1,118
Novartis Pharmaceuticals Corporation
$1,010
PFIZER INC.
$917
Genentech USA, Inc.
$871
Astellas Pharma US Inc
$743
Takeda Pharmaceuticals U.S.A., Inc.
$643
Eisai Inc.
$624
Boehringer Ingelheim Pharmaceuticals, Inc.
$605
Celgene Corporation
$590
GENZYME CORPORATION
$575
Merck Sharp & Dohme Corporation
$567
Merck Sharp & Dohme LLC
$518
GlaxoSmithKline, LLC.
$441
Bayer HealthCare Pharmaceuticals Inc.
$414
Exelixis Inc.
$363
Foundation Medicine, Inc.
$303
Lilly USA, LLC
$302
Alexion Pharmaceuticals, Inc.
$281
Daiichi Sankyo Inc.
$248
Kite Pharma, Inc.
$223
EISAI INC.
$219
Pharmacyclics LLC, An AbbVie Company
$205
Clovis Oncology, Inc.
$183
Seagen Inc.
$181
Karyopharm Therapeutics Inc.
$178
Gilead Sciences, Inc.
$177
Teva Pharmaceuticals USA, Inc.
$174
SOBI, INC
$163
Regeneron Healthcare Solutions, Inc.
$158
TESARO, Inc.
$147
Spectrum Pharmaceuticals Inc.
$141
ARRAY BIOPHARMA INC
$129
EMD Serono, Inc.
$129
Rigel Pharmaceuticals, Inc.
$116
Myovant Sciences Inc.
$114
TerSera Therapeutics LLC
$110
Taiho Oncology, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$100
Aveo Pharmaceuticals, Inc.
$94
ABBVIE INC.
$94
MorphoSys, US Inc.
$90
BeiGene USA, Inc.
$84
Deciphera Pharmaceuticals Inc.
$71
Puma Biotechnology, Inc.
$69
AbbVie Inc.
$66
PUMA BIOTECHNOLOGY, INC.
$66
Seattle Genetics, Inc.
$64
Ipsen Biopharmaceuticals, Inc
$59
AbbVie, Inc.
$59
Mirati Therapeutics, Inc.
$55
Coherus Biosciences Inc.
$42
TAIHO ONCOLOGY, INC.
$42
PharmaEssentia USA Corporation
$42
Stemline Therapeutics Inc.
$41
Novocure Inc.
$41
Sirtex Medical Inc
$40
Array BioPharma Inc.
$39
Dova Pharmaceuticals
$37
TOLMAR Pharmaceuticals, Inc.
$36
EUSA Pharma (US) LLC
$33
Janssen Pharmaceuticals, Inc
$33
CTI BioPharma Corp.
$29
Sumitomo Pharma America, Inc.
$28
GE HEALTHCARE
$27
Octapharma USA, Inc.
$25
ADC Therapeutics America, Inc.
$25
Pharmacyclics LLC, an AbbVie Company
$24
Organon LLC
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
MACROGENICS, INC.
$23
Fennec Pharmaceuticals, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
Epizyme, Inc.,
$20
Chiesi USA, Inc.
$18
Dendreon Pharmaceuticals LLC
$18
Sobi, Inc
$18
Mylan Institutional Inc.
$18
ACCORD HEALTHCARE, INC.
$17
Aurobindo Pharma USA, Inc.
$15
Acrotech Biopharma Inc.
$14
Secura Bio, Inc.
$14
Top 3 companies account for 23.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · FERRIPROX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · Fulphila · GAMIFANT · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Optune · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · QUZYTTIR · Quzyttir · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · Truxima · ULTOMIRIS · Udenyca · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
31
Per 100K population
1.0
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sapra is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sapra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sapra performed 363 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sapra receive payments from pharmaceutical companies?
Yes. Dr. Sapra received a total of $22,318 from 88 companies across 942 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sapra's costs compare to other medical oncologists in Fountain Valley?
Dr. Sapra's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sapra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fountain Valley
Browse medical oncologists in Fountain Valley ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in CA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in CA
Which CA medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology